Summary Adenium Biotech ApS (Adenium Biotech) is a biopharmaceutical company that develops and commercializes antibiotics for the treatment of drug resistant bacterial infections. The company provides products for the treating nosocomial infections such as hospital acquired pneumonia (HAP) or ventilator acquired pneumonia (VAP) and urinary tract infections caused by gram-negative and positive bacteria. Adenium Biotech offers arenicin, an antimicrobial peptide against gram-negative pathogens for urinary tract infection and pneumonia. It offers plectasin, an antibiotic, for treating Infective endocarditis (IE), meningitis and pneumonia. The company’s pipeline portfolio offers various products for treating infection cuased by Methicillin-resistant Staphylococcus aureus (MRSA) infections in patients with an osteo-or cardio implants. Adenium Biotech is headquartered in Copenhagen, Denmark. Adenium Biotech ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers... Research Beam Model: Research Beam Product ID: 1747430 250 USD New
Adenium Biotech ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile.
 
 

Adenium Biotech ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

  • Category : Pharmaceuticals
  • Published On : July   2017
  • Pages : 16
  • Publisher : GlobalData
 
 
 
Summary

Adenium Biotech ApS (Adenium Biotech) is a biopharmaceutical company that develops and commercializes antibiotics for the treatment of drug resistant bacterial infections. The company provides products for the treating nosocomial infections such as hospital acquired pneumonia (HAP) or ventilator acquired pneumonia (VAP) and urinary tract infections caused by gram-negative and positive bacteria. Adenium Biotech offers arenicin, an antimicrobial peptide against gram-negative pathogens for urinary tract infection and pneumonia. It offers plectasin, an antibiotic, for treating Infective endocarditis (IE), meningitis and pneumonia. The company’s pipeline portfolio offers various products for treating infection cuased by Methicillin-resistant Staphylococcus aureus (MRSA) infections in patients with an osteo-or cardio implants. Adenium Biotech is headquartered in Copenhagen, Denmark.

Adenium Biotech ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile. provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Adenium Biotech ApS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Adenium Biotech To Raise Funds Through Series A Financing 10
Adenium Biotech Raises US$1.84 Million In Venture Financing 10
Adenium Biotech Raises Funds Through Seed Financing 11
Adenium Biotech ApS - Key Competitors 13
Key Employees 14
Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Key Facts 1
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Adenium Biotech ApS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Adenium Biotech ApS, Deals By Therapy Area, 2011 to YTD 2017 8
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Adenium Biotech To Raise Funds Through Series A Financing 10
Adenium Biotech Raises US$1.84 Million In Venture Financing 10
Adenium Biotech Raises Funds Through Seed Financing 11
Adenium Biotech ApS, Key Competitors 13
Adenium Biotech ApS, Key Employees 14
List of Figures
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Adenium Biotech ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter